Heron Therapeutics Inc
Heron Therapeutics Inc (HRTX) Option Chain
Read more
Tracking the HRTX option chain helps you see every strike and expiry on Heron Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of HRTX options activity at a glance. Use our scanner to monitor the HRTX option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For HRTX stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where HRTX options are being actively traded, and where they are not.
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 98.62 | 353 | 0 | 0.05 | 0.00 | — | 0.05 | 0.50 | +92.31 | 0.10 | 0.50 | 0.24 | 0.06 | 1 | 13 | 1.38 |
| 100.00 | 2 | 0 | 1.20 | 0.00 | — | 1.20 | 1.00 | +284.62 | 0.70 | 1.00 | 0.74 | 0.11 | 7 | 14 | 0.00 |
| 100.00 | 0 | 0 | 1.20 | 0.00 | — | 1.20 | 1.50 | +476.92 | 1.20 | 1.50 | 1.24 | 0.11 | 24 | 14 | 0.00 |
| 100.00 | 0 | 0 | 1.20 | 0.00 | — | 1.20 | 2.00 | +669.23 | 1.70 | 2.00 | 1.74 | 0.11 | 4 | 9 | 0.00 |
| 100.00 | 0 | 0 | 1.20 | 0.00 | — | 1.20 | 3.00 | +1053.85 | 2.70 | 3.00 | 2.74 | 0.11 | 12 | 8 | 0.00 |
As of Nov 19, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank86.51% High
- Market cap (M$)50
- 52 weeks high-83.54%
- 52 weeks low0.00%
- Analyst recommendationHold
3.00 - Target price$0.34
29.77% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-0.11
- EPS growth next 5 years16.15%
As of Nov 19, 2026